Mary Beth Harler's most recent trade in IGM Biosciences Inc was a trade of 1,522 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IGM Biosciences Inc | Mary Beth Harler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 Jun 2025 | 1,522 | 338,181 (1%) | 0% | 1.2 | 1,825 | Common Stock |
| IGM Biosciences Inc | Mary Beth Harler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 14 Mar 2025 | 7,329 | 339,703 (1%) | 0% | 1.2 | 9,015 | Common Stock |
| IGM Biosciences Inc | Mary Beth Harler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.48 per share. | 16 Dec 2024 | 1,708 | 347,032 (1%) | 0% | 7.5 | 12,776 | Common Stock |
| IGM Biosciences Inc | Mary Beth Harler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 370,000 | 370,000 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Mary Beth Harler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 185,000 | 348,740 (1%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Mary Beth Harler | Head, Research & Autoimmunity | Sale of securities on an exchange or to another person at price $ 11.54 per share. | 13 Sep 2024 | 1,487 | 163,740 (0%) | 0% | 11.5 | 17,158 | Common Stock |
| IGM Biosciences Inc | Mary Beth Harler | Head, Research & Autoimmunity | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Jul 2024 | 200,000 | 0 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Mary Beth Harler | Head, Research & Autoimmunity | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 54,999 | 140,226 (0%) | 0% | - | Common Stock | |
| IGM Biosciences Inc | Mary Beth Harler | Head, Research & Autoimmunity | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 25,001 | 165,227 (0%) | 0% | - | Common Stock | |
| IGM Biosciences Inc | Mary Beth Harler | Head, Research & Autoimmunity | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 14 Jun 2024 | 1,570 | 85,227 (0%) | 0% | 7.6 | 11,893 | Common Stock |